Humacyte Inc. (HUMA)
NASDAQ: HUMA
· Real-Time Price · USD
1.61
-0.07 (-4.17%)
At close: Sep 25, 2025, 3:59 PM
1.63
1.24%
After-hours: Sep 25, 2025, 05:20 PM EDT
-4.17% (1D)
Bid | 1.61 |
Market Cap | 255.13M |
Revenue (ttm) | 8.05M |
Net Income (ttm) | -58.66M |
EPS (ttm) | -0.47 |
PE Ratio (ttm) | -3.43 |
Forward PE | -4.86 |
Analyst | Buy |
Dividends | n/a |
Ask | 1.72 |
Volume | 1,851,537 |
Avg. Volume (20D) | 4,477,674 |
Open | 1.65 |
Previous Close | 1.68 |
Day's Range | 1.61 - 1.67 |
52-Week Range | 1.15 - 6.77 |
Beta | 1.87 |
Ex-Dividend Date | n/a |
About HUMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HUMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HUMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsHumacyte Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+16.99%
Humacyte shares are trading higher after the compa...
Unlock content with
Pro Subscription
1 month ago
-29.44%
Humacyte shares are trading lower after the company reported worse-than-expected Q2 financial results.